BOXABL Inc. has appointed Timothy Goldsmith, a former EY audit partner with over 20 years of public company and SEC reporting experience, as chair of its Audit Committee. This move strengthens BOXABL's financial governance as the company expands its board and builds out its finance infrastructure following its recent public listing on Nasdaq. Goldsmith's expertise in audit strategy, compliance, and financial reporting will support BOXABL's growth and governance needs as it scales its innovative modular housing business. The company continues to enhance its leadership with recent CFO and accounting officer hires, signaling a strong focus on disciplined financial management.
BOXABL's recent board appointment news provides context for readers following Industrials-sector stocks. For readers following Industrials, here is Pluang's market snapshot as of Sep 24, 2026 16:31 WIB: Of 93 priced US Industrials stocks tradable on Pluang, 23 rose and 63 fell today. Notable movers include EXPD at USD 192.15 with a 1-day change of +2.19% and 100% buy order activity, MOD at USD 189.05 down 2.10%, and ACHR at USD 5.59 down 2.10% with 56% sell order activity.
Bank of America has been upgraded to a buy rating as its stock trades nearly 20% below fair value following a sharp selloff in Q3. The bank reported strong Q2 results with $1.21 GAAP EPS and $31.6 billion in revenue, driven by net interest income and...
Scottie Resources Corp. announced a private placement offering to raise up to C$10 million by selling 3,448,275 shares at C$2.90 each, with an option to raise an additional C$2 million. Alongside an amended non-brokered private placement of C$17 mill...
Bitcoin's market cap dropped by $49.1 billion in 24 hours, but analyst Ali Martinez expects a rally toward $100,000, citing strong support at $82,500. Bitcoin currently trades around $83,120, with a potential 20% upside after a possible consolidation...
Bitcoin's market cap dropped by $49.1 billion recently, but analyst Ali Martinez expects a rally to $100,000, citing a strong support level at $82,500. The price currently hovers around $83,120, with potential upside of over 20%. This optimism is sup...
Viking Therapeutics announced the pricing of its public offerings, raising up to $275 million through common stock and convertible senior notes. The company plans to use the proceeds to advance clinical development and commercialization of its obesit...
